References
- McMurray JJ, Adamopoulus S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Köber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rönnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (CHFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur J Heart Fail 2012;14:803–69.
- van Veldhuisen DJ, Linssen GCM, Jaarsma T, van Gilst WH, Hoes AW, Tijssen JGP, Paulus WJ, Voors AA, Hillege HL. B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 2013;61:1498–1506.
- Cheng V, Kazanagra R, Garcia A, Lenert L, Krishnaswamy P, Gardetto N. A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. J Am Coll Cardiol 2001;37:386–91.
- Maisel A, Barnard D, Jaski B, Frivold G, Marais J, Azer M, Miyamoto MI, Lombardo D, Kelsay D, Borden K, Iqbal N, Taub PR, Kupfer K, Clopton P, Greenberg B. Primary results of the HABIT trial (heart failure assessment with BNP in the home). J Am Colleg Cardiol 2013;61:1726–35.
- Ng LL, Geeranavar S, Jennings SC, Loke I, O’Brien J. Diagnosis of heart failure using urinary natriuretic peptides. Clin Sci 2004;106:129–33.
- Cortez R, Portoles M, Salvador A, Bertomeu V, de Burgos FG, Martinez-Dolz L, Lleti ER, Climent V, Jordán A, Payá R, Rivera M. Diagnostic and prognostic value of urine NT-proBNP levels in heart failure patients. Eur J Heart Fail 2006;8:621–7.
- Cortez R, Rivera M, Salvador A, Bertomeu V, de Burgos FG, Roselló-Lleti E, Portolés M, Payá R, Martinez-Dolz L, Climent V. Variability of NT-proBNP plasma and urine levels in patients with stable heart failure: a 2-year follow-up study. Heart 2007;93:957–62.
- Jungbauer CG, Buchner S, Birner C, Resch M, Heinicke N, Debl K, Buesing M, Biermeier D, Schmitz G, Riegger G, Luchner A. N-terminal pro-brain natriuretic peptide from fresh urine for the biochemical detection of heart failure and left ventricular dysfunction. Eur J Heart Fail 2010;12:331–7.
- Manzano-Fernández S, Januzzi JL, Boronat-García M, Pastor P, Albaladejo-Otón M, Garrido IP, Bayes-Genis A, Valdés M, Pascual-Figal DA. Impact of kidney dysfunction on plasma and urinary N-terminal pro-B-type natriuretic peptide in patients with acute heart failure. Congest Heart Fail 2010;16:214–20.
- Schou M, Dalsgaard MK, Clemmesen O, Dawson EA, Yoshiga CC, Nielsen HB, Gustafsson F, Hildebrandt PR. Secher NH. Kidneys extract BNP and NT-proBNP in healthy young men. J Appl Physiol 2005;99:1676–80.
- Linssen GC, Damman K, Hillege HL, Navis G, van Veldhuisen DJ, Voors AA. Urinary N-terminal prohormone brain natriuretic peptide excretion in patients with chronic heart failure. Circulation 2009;120:35–41.
- Shin DI, Jaekel K, Shley P, Sause A, Müller M, Fueth R, Scheffold T, Guelker H, Horlitz M. Plasma levels of NR-proBNP in patients with atrial fibrillation before and after electrical cardioversion. Z Kardiol 2005;94:795–800.
- Linssen GCM, Rienstra M, Jaarsma T, Voors AA, van Gelder IC, Hillege HL, van Veldhuisen DJ. Clinical and prognostic effects of atrial fibrillation in heart failure patients with reduced and preserved left ventricular ejection fraction. Eur J Heart Fail 2011;13:1111–20.
- Boyne JJ, Vrijhoef HJ, Spreeuwenberg M, De Weerd G, Kragten J, Gorgels AP; TEHAF Investigators. Effects of tailored telemonitoring on heart failure patients’ knowledge, self-care, self-efficacy and adherence: a randomized controlled trial. Eur J Cardiovasc Nurs 2014;13:243–52.
- Stålhammar J, Stern L, Linder R, Parikh SSR, Ariely R, Wikström G. Resource utilization and cost of heart failure associated with reduced ejection fraction in Swedish patients. J Med Econ 2012;5:938–94.